“Molecular Docking, Pre-ADME, And Pre-Tox Analysis Of Swainsonine And Castanospermine As Potential Glucokinase Activators”, Journal of Pharmaceutical Negative Results, pp. 6456–6464, Dec. 2022, doi: 10.47750/.